Vaccine Adjuvants Market Growth, Demand and Challenges of the Key Industry Players

1
Global Vaccine Adjuvants Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Vaccine Adjuvants Market Research Report
2022-2027 The latest report by IMARC, titled
Vaccine Adjuvants Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2022-2027, finds that the global
vaccine adjuvants market size reached US 773.6
Million in 2021. Vaccine adjuvants are
compounds that improve the bodys immunogenic
response against antigens. They increase the
ability of the vaccines to induce long-term
protection against infections. Presently,
aluminum salts and MF59 are the only adjuvants
found fit for human use. In recent years, the
demand for vaccine adjuvants has escalated as
they increase antibody titers, reduce required
antigen doses, induce a rapid immune response and
long-lasting memory, and enhance the immune
response in the elderly and young children.
Request for a PDF sample of this report
https//www.imarcgroup.com/vaccine-adjuvants-marke
t/requestsample

4
Report Description and Highlights
Report Description
Global Vaccine Adjuvants Market Trends One of
the primary factors driving the market is the
rising incidences of infectious diseases and
allergies, such as human immunodeficiency virus
(HIV/AIDS), cancer, human papillomavirus (HPV),
and tuberculosis. Additionally, the need for
advanced treatment options for prevailing and
emerging fatal diseases has increased the need to
develop vaccines possessing long-lasting effects
on immunization. Other than this, governments of
numerous nations are taking initiatives for
immunization and improvements in adjuvants for
human consumption. They are also focusing on
enhancing the healthcare infrastructure and
increasing investments in research and
development (RD) of new therapeutics, which is
creating a positive market outlook. Furthermore,
with the sudden coronavirus (COVID-19) outburst,
the demand for effective and safe vaccine
adjuvants is constantly increasing. On account
of these factors, IMARC Group expects the market
value to reach US 1,617.3 Million by 2027,
expanding at a CAGR of 12.82 during the forecast
period (2022-2027). View Report TOC, Figures and
Tables https//www.imarcgroup.com/vaccine-adjuvan
ts-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product Type
• Adjuvant Emulsions
• Pathogen Components
• Particulate Adjuvants
• Combination Adjuvants
• Others
•  
• Breakup by Route of Administration
• Oral
• Intramuscular
• Intranasal
• Subcutaneous
• Intradermal
• Others

6
Report Description and Highlights
Report Description

•  
• Breakup by Diseases
• Cancer
• Infectious Diseases
• Others
• Breakup by Application
• Research
• Commercial
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa 

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Adjuvance Tecchnologies Inc.
• Adjuvatis, Agenus Inc.
• Brenntag SE
• Chemtrade Logistics Inc.
• CSL Limited
• Croda International Plc
• Invivogen
• Novavax Inc.
• OZ Biosciences
• Virometix AG.
•  

8
Table of Contents
Report Description
1   Preface2   Scope and Methodology    2.1  
 Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3   Executive Summary4  
Introduction    4.1    Overview    4.2    Key
Industry Trends5   Global Vaccine Adjuvants
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

9
Table of Contents
Report Description
6   Market Breakup by Product Type    6.1  
 Adjuvant Emulsions        6.1.1 Market Trends 
      6.1.2 Market Forecast    6.2    Pathogen
Components        6.2.1 Market Trends       
6.2.2 Market Forecast    6.3    Particulate
Adjuvants        6.3.1 Market Trends       
6.3.2 Market Forecast    6.4    Combination
Adjuvants        6.4.1 Market Trends       
6.4.2 Market Forecast    6.5    Others       
6.5.1 Market Trends        6.5.2 Market
Forecast          Click here to visit the
complete table of content with list of figures
and tables https//www.imarcgroup.com/vaccine-adj
uvants-market/toc

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us